Is the Apgar Score Outmoded?

The Lancet

Volumn 333, Issue 8638, 1989, Pages 591-592

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

APGAR SCORE; EDITORIAL; HUMAN; NEWBORN; PRIORITY JOURNAL;

APGAR SCORE; EVALUATION STUDIES; HUMAN; INFANT, NEWBORN; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME; RESUSCITATION;

EID: 84921620571     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)91614-0     Document Type: Article

References (28)

1. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease a review of randomised controlled trials
2. Type II diabetes mellitus: interface between clinical and epidemiological investigation
3. Improved beta cell function after intensive insulin treatment m severe non-insulin dependent diabetes
4. When to use insulin in the maturity-onset diabetic
5. A proposal for a new method of evaluation of the newborn infant
6. The newborn (Apgar) scoring system. Reflections and advice
7. Further observations on the newborn scoring system
8. Evaluation of the newborn infant—second report
9. Assessment of the Apgar score
10. The Apgar score revisited: influence of gestational age
11. Apgar scores and umbilical arterial pH in preterm newborn infants
12. Do Apgar scores indicate asphyxia?
13. The Apgar score is it enough?
14. Asphyxia and the Apgar score
15. The relationships among the fetal biophysical profile, umbilical cord pH and Apgar scores
16. Umbilical cord pH and Apgar scores as an index of neonatal health
17. Resuscitation of the newborn
18. Death as an option in neonatal intensive care
19. The Apgar scoring of newborn infants and its relation to neonatal mortality
20. Nimodipine improves outcome when given after complete cerebral ischemia in primates
21. Postasphyxial cerebral survival in newborn sheep after treatment with oxygen free radical scavengers and a calcium antagonist
22. Leucocyte dependent histamine release from rabbit platelets: The role of IgE, basophils and a platelet activating factor
23. Platelet activating factor and asthma
24. Effect of platelet-activating factor on airway vascular permeability. possible mechanisms
25. Airway microvascular and epithelial leakage of plasma induced by PAF-acether (PAF) and capsaicin (CAP)
26. Inflammatory leakage of macromolecules from the vascular compartment into the tracheal lumen
27. Platelet activating factor increases protein exudation but not mucus secretion in guinea-pig trachea in vivo
28. Reduced tracheal mucus velocity in guinea-pig in vivo by platelet activating factor